Medical experts discuss lymphoma diagnosis and treatment advancements

Medical experts are clarifying the distinctions between lymphoma and traditional cancers while highlighting advancements in diagnosis and treatment. Dr. Germán Stemmelin, Head of Hematology at Hospital Británico, explains that while lymphoma is a malignant disease, it differs from typical cancers because it lacks a single primary site of origin, does not typically involve metastasis, and does not usually require surgery for therapeutic purposes.

In Spain, the Hospital Universitario Rey Juan Carlos recently held a workshop for patients and families to address the complexities of the disease. Experts note that lymphoma is a heterogeneous group of hematological diseases rather than a single condition. Recent estimates from the Spanish Society of Hematology and Hemotherapy suggest that approximately 12,000 new lymphoma cases will be diagnosed in Spain in 2026. Medical professionals emphasize that progress in personalized medicine and diagnostic tools is increasing the possibilities for long-term control and cure.